Authors

• Francesca Colavita (ORCID: https://orcid.org/0000-0003-0640-8667)
• Stefania Notari
• Alessandro Sette (ORCID: https://orcid.org/0000-0001-7013-2250)
• Assunta Navarra (ORCID: https://orcid.org/0000-0002-3662-4312)
• Carla Tortorella (ORCID: https://orcid.org/0000-0001-9037-7300)
• Shalom Haggiag (ORCID: https://orcid.org/0000-0002-5569-4121)
• Maria Esmeralda Quartuccio
• Claudio Gasperini (ORCID: https://orcid.org/0000-0002-3959-4067)
• Anna Maria Gerarda Altera
• Alessandra Aiello (ORCID: https://orcid.org/0000-0003-2681-9383)
• Fabrizio Maggi (ORCID: https://orcid.org/0000-0001-7489-5271)
• Serena Ruggieri (ORCID: https://orcid.org/0000-0001-5287-3290)
• Silvia Meschi (ORCID: https://orcid.org/0000-0003-0924-993X)
• Emanuele Nicastri (ORCID: https://orcid.org/0000-0002-5606-8712)
• Gilda Cuzzi (ORCID: https://orcid.org/0000-0002-4305-2199)
• Delia Goletti (ORCID: https://orcid.org/0000-0001-8360-4376)
• Eleonora Cimini (ORCID: https://orcid.org/0000-0002-2659-0868)
• Simonetta Galgani
• Valentina Vanini (ORCID: https://orcid.org/0000-0001-8476-964X)
• Andrea Salmi (ORCID: https://orcid.org/0000-0001-9141-7909)
• Luca Prosperini (ORCID: https://orcid.org/0000-0003-3237-6267)
• Alba Grifoni (ORCID: https://orcid.org/0000-0002-2209-5966)
• Vincenzo Puro (ORCID: https://orcid.org/0000-0003-0291-4490)

Institutions

• La Jolla Institute for Immunology (US)
• University of California San Diego (US)
• Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani (IT)
• Azienda Ospedaliera San Camillo-Forlanini (IT)
• Istituti di Ricovero e Cura a Carattere Scientifico (IT)

Publication Details

Journal

Frontiers in Immunology

Published

2025-10-30

DOI

https://doi.org/10.3389/fimmu.2025.1682049

Primary Topic

SARS-CoV-2 and COVID-19 Research

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Ministero della Salute